Background: End-of-life care for patients with advanced chronic kidney disease (CKD) is recognised as an important area for improvement. These patients have a significant mortality and, although some is unpredictable, there is a role for the nephrology multi-disciplinary team (MDT) and palliative care physicians to engage in advance care planning and support patients to discuss their preferences. Methods: Retrospective and prospective data were obtained to conduct a comparison observational study to assess the impact of introducing a supportive care register on the end-of-life care for patients with advanced CKD. An electronic supportive care register was implemented. This required a programme of multi-disciplinary staff education, collaborative working with Palliative Care to establish renal-specific protocols and dissemination activities. The impact of the intervention was assessed by analysing all deaths in two six-month periods where all those with an eGFR <15 ml/min/1.73 m2 at the time of their death were included. Results: A total of 91 patients were included. Post-intervention, there was a 25.4% (95% CI: 6.5-44.3%, p = 0.008) improvement in patients having a documented discussion about end-of-life planning. There was also a 19.7% (95% CI: 4.0-35.5%, p = 0.01) improvement in establishing the place of death. All patients who expressed a preferred place of death died there. The intervention increased engagement with the wider MDT and led to significant improvements in access to specialist palliative care services. Conclusions: These results show that the interventions implemented to introduce a supportive care register resulted in meaningful improvements to the end-of-life care for patients in our region with advanced CKD.

Keywords:
Chronic renal disease, Dialysis, End-of-life care, End-stage renal disease, Palliative care
1.
NHS Kidney Care National End of Life Care Programme: End of Life Care in Advanced Kidney Disease: A Framework for Implementation. Suffolk, 2009, pp 1-48.
2.
Department of Health: Part Two: Chronic kidney disease, acute renal failure and end of life care; in DH Renal NSF Team (ed): The National Service Framework for Renal Services. London, 2005, pp 21-23.
3.
European Renal Best Practice: A new European guideline on CKD management in frail or elderly patients. ERBP needs your help! 2012, p 1.
4.
Fassett RG, Robertson IK, Mace R, Youl L, Challenor S, Bull R: Palliative care in end-stage kidney disease. Nephrology (Carlton) 2011;16:4-12.
5.
Renal Physicians Association: Shared Decision-Making in the Appropriate Initiation of and Withdrawal from Dialysis: Clinical Practice Guideline. Maryland, Rockville, 2010, pp 1-10.
6.
Gunda S, Thomas M, Smith S: National survey of palliative care in end-stage renal disease in the UK. Nephrol Dial Transplant 2005;20:392-395.
7.
Kane PM, Vinen K, Murtagh FE: Palliative care for advanced renal disease: a summary of the evidence and future direction. Palliat Med 2013;27:817-821.
8.
Murray SA, Kendall M, Boyd K, Sheikh A: Illness trajectories and palliative care. BMJ 2005;330:1007-1011.
9.
Murtagh FE, Murphy E, Sheerin NS: Illness trajectories: an important concept in the management of kidney failure. Nephrol Dial Transplant 2008;23:3746-3748.
10.
Holley JL: Palliative care in end-stage renal disease: focus on advance care planning, hospice referral, and bereavement. Semin Dial 2005;18:154-156.
11.
Davison R, Sheerin NS: Prognosis and management of chronic kidney disease (CKD) at the end of life. Postgrad Med J 2014;90:98-105.
12.
Moss AH, Ganjoo J, Sharma S, Gansor J, Senft S, Weaner B, Dalton C, MacKay K, Pellegrino B, Anantharaman P, Schmidt R: Utility of the ‘surprise' question to identify dialysis patients with high mortality. Clin J Am Soc Nephrol 2008;3:1379-1384.
13.
The Gold Standards Framework, Royal College of General Practitioners: The GSF Prognostic Indicator Guidance, 2011, pp 1-4.
14.
Hobson K, Gomm S, Murtagh F, Caress AL: National survey of the current provision of specialist palliative care services for patients with end-stage renal disease. Nephrol Dial Transplant 2011;26:1275-1281.
15.
Trivedi DD: Palliative dialysis in end-stage renal disease. Am J Hosp Palliat Care 2011;28:539-542.
16.
O'Connor NR, Kumar P: Conservative management of end-stage renal disease without dialysis: a systematic review. J Palliat Med 2012;15:228-235.
17.
Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE: Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant 2007;22:1955-1962.
18.
Davison SN: End-of-life care preferences and needs: perceptions of patients with chronic kidney disease. Clin J Am Soc Nephrol 2010;5:195-204.
19.
Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA: Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 2000;284:2476-2482.
20.
Almack K, Cox K, Moghaddam N, Pollock K, Seymour J: After you: conversations between patients and healthcare professionals in planning for end of life care. BMC Palliat Care 2012;11:15.
21.
Arnold E, Finucane AM, Oxenham D: Preferred place of death for patients referred to a specialist palliative care service. BMJ Support Palliat Care 2013, Epub ahead of print.
22.
Bayliss EA, Bhardwaja B, Ross C, Beck A, Lanese DM: Multidisciplinary team care may slow the rate of decline in renal function. Clin J Am Soc Nephrol 2011;6:704-710.
23.
Murtagh FE, Addington-Hall J, Higginson IJ: The prevalence of symptoms in end-stage renal disease: a systematic review. Adv Chronic Kidney Dis 2007;14:82-99.
24.
Davison SN, Jhangri GS, Holley JL, Moss AH: Nephrologists' reported preparedness for end-of-life decision-making. Clin J Am Soc Nephrol 2006;1:1256-1262.
25.
Holley JL, Carmody SS, Moss AH, Sullivan AM, Cohen LM, Block SD, Arnold RM: The need for end-of-life care training in nephrology: national survey results of nephrology fellows. Am J Kidney Dis 2003;42:813-820.
26.
Cohen LM, Germain M, Poppel DM, Woods A, Kjellstrand CM: Dialysis discontinuation and palliative care. Am J Kidney Dis 2000;36:140-144.
27.
Cox K, Moghaddam N, Almack K, Pollock K, Seymour J: Is it recorded in the notes? Documentation of end-of-life care and preferred place to die discussions in the final weeks of life. BMC Palliat Care 2011;10:18.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.